Skip to content
Guavy Logo GUAVY
Sign up
Back to Guavy Wire
Stocks

Erste Group Bank Lowers Earnings Forecast for Amgen Amid Pipeline Concerns

Guavy AI Editorial Team
Instruments
AMGN
Share

Erste Group Bank analysts have reduced their forecast for Amgen's FY2027 earnings per share (EPS) to $23.50, down from a previous estimate of $23.58.

This downward revision comes as part of the company's quarterly report for Q2 2026, which exceeded expectations with revenue of $10.05 billion and adjusted EPS of $6.29.

Despite this positive news, the decision to discontinue Amgen's obesity drug candidate AMG 513 has raised concerns among investors about the company's pipeline performance.

More on Stocks

Stocks just now

Storage Becomes Frontline Defense as Resilience Takes Center Stage

Stocks just now

MIT, IBM Launch AI Lab to Democratize Access to Artificial Intelligence in India

Stocks just now

IBM's Apptio Aims to Close Gap Between AI Spend and Business Results

Disclaimer: Guavy is a data and market intelligence provider, not an investment advisor. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Guavy Logo GUAVY

Market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

Navigate

Markets

Resources

© 2026 Guavy Inc

Terms Privacy Policy